Although miR-107 expression is down-regulated in glioma tissues and cell lines, its overexpression can directly target and regulate Notch2, which inhibits the migratory and invasive capacity of glioma cells, a known target for Tenascin-C and COX-2 trans-activation (Chen et al., 2013). Here, NOTCH2 is linked to central nervous system cancer.